Humoral innate immunity and acute-phase proteins
A Mantovani, C Garlanda - New England Journal of Medicine, 2023 - Mass Medical Soc
Humoral Innate Immunity and Acute-Phase Proteins | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection
SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …
[HTML][HTML] An immune-based biomarker signature is associated with mortality in COVID-19 patients
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) contribute to disease severity of coronavirus disease 2019 (COVID-19) …
(SARS-CoV-2) contribute to disease severity of coronavirus disease 2019 (COVID-19) …
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
FX Lescure, H Honda, RA Fowler, JS Lazar… - The Lancet …, 2021 - thelancet.com
Background Elevated proinflammatory cytokines are associated with greater COVID-19
severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor …
severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor …
Biomarkers in COVID-19: an up-to-date review
M Samprathi, M Jayashree - Frontiers in pediatrics, 2021 - frontiersin.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …
Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions
Objective Risk factors for in-hospital mortality in confirmed COVID-19 patients have been
summarized in numerous meta-analyses, but it is still unclear whether they vary according to …
summarized in numerous meta-analyses, but it is still unclear whether they vary according to …
Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
Background The interaction between COVID-19, non-communicable diseases, and chronic
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …
COVID-19 ICU and mechanical ventilation patient characteristics and outcomes—A systematic review and meta-analysis
R Chang, KM Elhusseiny, YC Yeh, WZ Sun - PloS one, 2021 - journals.plos.org
Background Insight into COVID-19 intensive care unit (ICU) patient characteristics, rates and
risks of invasive mechanical ventilation (IMV) and associated outcomes as well as any …
risks of invasive mechanical ventilation (IMV) and associated outcomes as well as any …
[HTML][HTML] Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19
N Ali - Journal of medical virology, 2020 - ncbi.nlm.nih.gov
To the Editor, The outbreak of coronavirus disease‐2019 (COVID‐19) is an emerging global
health threat. The healthcare workers are facing challenges in reducing the severity and …
health threat. The healthcare workers are facing challenges in reducing the severity and …
COVID-19 and myocarditis: a systematic review and overview of current challenges
Myocardial inflammation in COVID-19 has been documented. Its pathogenesis is not fully
elucidated, but the two main theories foresee a direct role of ACE2 receptor and a …
elucidated, but the two main theories foresee a direct role of ACE2 receptor and a …